{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Paeoniae Radix Alba", "UPLC-Q Exactive Orbitrap HRMS", "network pharmacology", "non-alcoholic fatty liver disease", "sequential metabolism", "surface plasmon resonance"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34604271", "DateRevised": {"Year": "2021", "Month": "10", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "09", "Day": "16"}], "Language": ["eng"], "ELocationID": ["677659", "10.3389/fnut.2021.677659"], "Journal": {"ISSN": "2296-861X", "JournalIssue": {"Volume": "8", "PubDate": {"Year": "2021"}}, "Title": "Frontiers in nutrition", "ISOAbbreviation": "Front Nutr"}, "ArticleTitle": "Mechanism of <i>Paeoniae Radix Alba</i> in the Treatment of Non-alcoholic Fatty Liver Disease Based on Sequential Metabolites Identification Approach, Network Pharmacology, and Binding Affinity Measurement.", "Pagination": {"StartPage": "677659", "MedlinePgn": "677659"}, "Abstract": {"AbstractText": ["Screening functional food ingredients (FFI) from medicinal and edible plants (MEP) has still remained a great challenge due to the complexity of MEP and its obscure function mechanisms. Herein, an integrated strategy based on sequential metabolites identification approach, network pharmacology, molecular docking, and surface plasmon resonance (SPR) analysis was proposed for quickly identifying the active constituents in MEP. First, the sequential biotransformation process of MEP, including intestinal absorption and metabolism, and hepatic metabolism, was investigated by oral gavage, and intestinal perfusion with venous sampling method. Then the blood samples were analyzed by UPLC-Q Exactive Orbitrap HRMS. Second, the network pharmacology approach was used to explore the potential targets and possible mechanisms of the <i>in vivo</i> metabolites of MEP. Third, molecular docking and SPR approaches were used to verify the specific interactions between protein targets and representative ingredients. The proposed integrated strategy was successfully used to explore the heptoprotective components and the underlying molecular mechanism of <i>Paeoniae Radix Alba</i> (PRA). A total of 44 compounds were identified in blood samples, including 17 porotypes and 27 metabolites. The associated metabolic pathways were oxidation, methylation, sulfation, and glucuronidation. After further screening, 31 bioactive candidates and 377 related targets were obtained. In addition, the bioactive components contained in PRA may have therapeutic potentials for non-alcoholic fatty liver disease (NAFLD). The above results demonstrated the proposed strategy may provide a feasible tool for screening FFI and elaborating the complex function mechanisms of MEP."], "CopyrightInformation": "Copyright \u00a9 2021 Luo, Liu, Han, Yang, Wang, Wang, Jiang, Sen, Li, Yu and Shi."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China."}, {"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China."}], "LastName": "Luo", "ForeName": "Zhiqiang", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China."}], "LastName": "Liu", "ForeName": "Yang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China."}], "LastName": "Han", "ForeName": "Xing", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China."}], "LastName": "Yang", "ForeName": "Wenning", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zhongcai Health (Beijing) Biological Technology Development Co., Ltd., Beijing, China."}], "LastName": "Wang", "ForeName": "Guopeng", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China."}], "LastName": "Wang", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China."}], "LastName": "Jiang", "ForeName": "Xiaoquan", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China."}], "LastName": "Sen", "ForeName": "Muli", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China."}], "LastName": "Li", "ForeName": "Xueyan", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China."}], "LastName": "Yu", "ForeName": "Guohua", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China."}, {"Identifier": [], "Affiliation": "Department of Biomedical Engineering, Shenzhen Research Institute, Beijing University of Chinese Medicine, Shenzhen, China."}], "LastName": "Shi", "ForeName": "Yuanyuan", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Nutr", "NlmUniqueID": "101642264", "ISSNLinking": "2296-861X"}, "CoiStatement": "GW was employed by company Zhongcai Health (Beijing) Biological Technology Development Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Guo R, Luo X, Liu J, Liu L, Wang X, Lu H. Omics strategies decipher therapeutic discoveries of traditional Chinese medicine against different diseases at multiple layers molecular-level. Pharmacol Res. (2020) 152:104627. 10.1016/j.phrs.2020.104627", "ArticleIdList": ["10.1016/j.phrs.2020.104627", "31904505"]}, {"Citation": "Feng G, Sun Y, Liu S, Song F, Pi Z, Liu Z. Stepwise targeted matching strategy from in vitro to in vivo based on ultra\u2013high performance liquid chromatography tandem mass spectrometry technology to quickly identify and screen pharmacodynamic constituents. Talanta. (2019) 194:619\u201326. 10.1016/j.talanta.2018.10.074", "ArticleIdList": ["10.1016/j.talanta.2018.10.074", "30609581"]}, {"Citation": "Annunziata G, Maisto M, Schisano C, Ciampaglia R, Daliu P, Narciso V, et al. . Colon bioaccessibility and antioxidant activity of white, green and black tea polyphenols extract after in vitro simulated gastrointestinal digestion. Nutrients. (2018) 10:1711. 10.3390/nu10111711", "ArticleIdList": ["10.3390/nu10111711", "PMC6266738", "30413043"]}, {"Citation": "Luo Z, Ma X, Liu Y, Lu L, Yang R, Yu G, et al. . An approach to characterizing the complicated sequential metabolism of salidroside in rats. Molecules. (2016) 21:706. 10.3390/molecules21060706", "ArticleIdList": ["10.3390/molecules21060706", "PMC6272855", "27248984"]}, {"Citation": "Zhang L, Zhao H, Liu Y, Dong H, Lv B, Fang M, et al. . Metabolic routes along digestive system of licorice: multicomponent sequential metabolism method in rat. Biomed Chromatogr. (2016) 30:902\u201312. 10.1002/bmc.3626", "ArticleIdList": ["10.1002/bmc.3626", "26418123"]}, {"Citation": "Schanker LS, Tocco DJ, Brodie BB, Hogben CA. Absorption of drugs from the rat small intestine. J Pharmacol Exp Ther. (1958) 123:81\u201388. PubMed PMID:13539795.", "ArticleIdList": ["13539795"]}, {"Citation": "Luo Z, Liu Y, Zhao B, Tang M, Dong H, Zhang L, et al. . Ex vivo and in situ approaches used to study intestinal absorption. J Pharmacol Toxicol Methods. (2013) 68:208\u201316. 10.1016/j.vascn.2013.06.001", "ArticleIdList": ["10.1016/j.vascn.2013.06.001", "23831587"]}, {"Citation": "Gong J, Jiang Z, Yang T, Zhu Y. In vitro and in vivo pharmacokinetics and metabolism of MK-8353 by liquid chromatography combined with diode array detector and Q-Exactive-Orbitrap tandem mass spectrometry. J Pharm Biomed Anal. (2019) 168:64\u201374. 10.1016/j.jpba.2019.02.012", "ArticleIdList": ["10.1016/j.jpba.2019.02.012", "30797103"]}, {"Citation": "Han F, Li Y, Ma L, Liu T, Wu Y, Xu R, et al. . A rapid and sensitive UHPLC-FT-ICR MS/MS method for identification of chemical constituents in Rhodiola crenulata extract, rat plasma and rat brain after oral administration. Talanta. (2016) 160:183\u201393. 10.1016/j.talanta.2016.07.014", "ArticleIdList": ["10.1016/j.talanta.2016.07.014", "27591603"]}, {"Citation": "Liu R, Liu Q, Li B, Liu L, Cheng D, Cai X, et al. . Pharmacokinetics, bioavailability, excretion, and metabolic analysis of Schisanlactone E, a bioactive ingredient from Kadsura heteroclita (Roxb) Craib, in rats by UHPLC\u2013MS/MS and UHPLC-Q-Orbitrap HRMS. J Pharm Biomed Anal. (2020) 177:112875. 10.1016/j.jpba.2019.112875", "ArticleIdList": ["10.1016/j.jpba.2019.112875", "31546138"]}, {"Citation": "Liu Y, Xing H, Jiang X, Chen Y, Huang M, Yu S. Network pharmacology-based preventive effect of XZF on cutaneous toxicities induced by EGFR inhibitor. Biomed Pharmacother. (2020) 123:109755. 10.1016/j.biopha.2019.109755", "ArticleIdList": ["10.1016/j.biopha.2019.109755", "31926375"]}, {"Citation": "Wang YL, Cui T, Li YZ, Liao ML, Zhang HB, Hou WB, et al. . Prediction of quality markers of traditional Chinese medicines based on network pharmacology. Chinese Herbal Medicines. (2019) 11:349\u201356. 10.1016/j.chmed.2019.08.003", "ArticleIdList": ["10.1016/j.chmed.2019.08.003"]}, {"Citation": "Zeng Q, Li L, Siu W, Jin Y, Cao M, Li W, et al. . A combined molecular biology and network pharmacology approach to investigate the multi-target mechanisms of Chaihu Shugan San on Alzheimer's disease. Biomed Pharmacother. (2019) 120:109370. 10.1016/j.biopha.2019.109370", "ArticleIdList": ["10.1016/j.biopha.2019.109370", "31563815"]}, {"Citation": "Yu G, Luo Z, Zhou Y, Zhang L, Wu Y, Ding L, et al. . Uncovering the pharmacological mechanism of Carthamus tinctorius L. on cardiovascular disease by a systems pharmacology approach. Biomed Pharmacother. (2019) 117:109094. 10.1016/j.biopha.2019.109094", "ArticleIdList": ["10.1016/j.biopha.2019.109094", "31203131"]}, {"Citation": "Luo Z, Yu G, Chen X, Liu Y, Zhou Y, Wang G, et al. . Integrated phytochemical analysis based on UHPLC-LTQ-Orbitrap and network pharmacology approaches to explore the potential mechanism of Lycium ruthenicum Murr. for ameliorating Alzheimer's disease. Food Funct. (2020) 11:1362\u201372. 10.1039/C9FO02840D", "ArticleIdList": ["10.1039/C9FO02840D", "31967149"]}, {"Citation": "Wang J, Zhang Y, Liu YM, Yang XC, Chen YY, Wu GJ, et al. . Uncovering the protective mechanism of Huoxue Anxin Recipe against coronary heart disease by network analysis and experimental validation. Biomed Pharmacother. (2020) 121:109655. 10.1016/j.biopha.2019.109655", "ArticleIdList": ["10.1016/j.biopha.2019.109655", "31734577"]}, {"Citation": "Yang B, Wang N, Wang S, Li X, Zheng Y, Li M, et al. . Network-pharmacology-based identification of caveolin-1 as a key target of Oldenlandia diffusa to suppress breast cancer metastasis. Biomed Pharmacother. (2019) 112:108607. 10.1016/j.biopha.2019.108607", "ArticleIdList": ["10.1016/j.biopha.2019.108607", "30784915"]}, {"Citation": "Ren W, Luo Z, Pan F, Liu J, Sun Q, Luo G, et al. . Integrated network pharmacology and molecular docking approaches to reveal the synergistic mechanism of multiple components in Venenum Bufonis for ameliorating heart failure. PeerJ. (2020) 8:e10107. 10.7717/peerj.10107", "ArticleIdList": ["10.7717/peerj.10107", "PMC7605218", "33194384"]}, {"Citation": "Qin H, Chen H, Zou Y, Zhang X, Wei C, Chen W, et al. . Systematic investigation of the mechanism of Cichorium glandulosum on type 2 diabetes mellitus accompanied with non-alcoholic fatty liver rats. Food Funct. (2019) 10:2450\u201360. 10.1039/C8FO02284D", "ArticleIdList": ["10.1039/C8FO02284D", "30969285"]}, {"Citation": "Yu G, Zhang Y, Ren W, Dong L, Li J, Geng Y, et al. . Network pharmacology-based identification of key pharmacological pathways of Yin-Huang-Qing-Fei capsule acting on chronic bronchitis. Int J Chron Obstruct Pulmon Dis. (2016) 12:85\u201394. 10.2147/COPD.S121079", "ArticleIdList": ["10.2147/COPD.S121079", "PMC5191847", "28053519"]}, {"Citation": "Lv X, Xu Z, Xu G, Li H, Wang C, Chen J, et al. . Investigation of the active components and mechanisms of Schisandra chinensis in the treatment of asthma based on a network pharmacology approach and experimental validation. Food Funct. (2020) 11:3032\u201342. 10.1039/D0FO00087F", "ArticleIdList": ["10.1039/D0FO00087F", "32186565"]}, {"Citation": "Yu G, Wang W, Wang X, Xu M, Zhang L, Ding L, et al. . Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis. BMC Complement Altern Med. (2018) 18:292. 10.1186/s12906-018-2356-9", "ArticleIdList": ["10.1186/s12906-018-2356-9", "PMC6211468", "30382864"]}, {"Citation": "Zhang W, Chen Y, Jiang H, Yang J, Wang Q, Du Y, et al. . Integrated strategy for accurately screening biomarkers based on metabolomics coupled with network pharmacology. Talanta. (2020) 211:120710. 10.1016/j.talanta.2020.120710", "ArticleIdList": ["10.1016/j.talanta.2020.120710", "32070601"]}, {"Citation": "Ou C, Geng T, Wang J, Gao X, Chen X, Luo X, et al. . Systematically investigating the pharmacological mechanism of Dazhu Hongjingtian in the prevention and treatment of acute mountain sickness by integrating UPLC/Q-TOF-MS/MS analysis and network pharmacology. J Pharm Biomed Anal. (2020) 179:113028. 10.1016/j.jpba.2019.113028", "ArticleIdList": ["10.1016/j.jpba.2019.113028", "31835126"]}, {"Citation": "Yang Y, Wang Q, Guo D. A novel strategy for analyzing RNA-protein interactions by surface plasmon resonance biosensor. Mol Biotechnol. (2008) 40:87\u201393. 10.1007/s12033-008-9066-3", "ArticleIdList": ["10.1007/s12033-008-9066-3", "PMC7090661", "18465270"]}, {"Citation": "Fisher RJ, Fivash M. Surface plasmon resonance based methods for measuring the kinetics and binding affinities of biomolecular interactions. Curr Opin Biotechnol. (1994) 5:389\u201395. 10.1016/0958-1669(94)90047-7", "ArticleIdList": ["10.1016/0958-1669(94)90047-7", "7765171"]}, {"Citation": "He Q, Chen Y, Shen D, Cui X, Zhang C, Yang H, et al. . Development of a surface plasmon resonance immunosensor and ELISA for 3-nitrotyrosine in human urine. Talanta. (2019) 195:655\u201361. 10.1016/j.talanta.2018.11.110", "ArticleIdList": ["10.1016/j.talanta.2018.11.110", "30625597"]}, {"Citation": "Homola J. Surface plasmon resonance sensors for detection of chemical and biological species. Chem Rev. (2008) 108:462\u201393. 10.1021/cr068107d", "ArticleIdList": ["10.1021/cr068107d", "18229953"]}, {"Citation": "Koyun S, Akg\u00f6n\u00fcll\u00fc S, Yavuz H, Erdem A, Denizli A. Surface plasmon resonance aptasensor for detection of human activated protein C. Talanta. (2019) 194:528\u201333. 10.1016/j.talanta.2018.10.007", "ArticleIdList": ["10.1016/j.talanta.2018.10.007", "30609568"]}, {"Citation": "Sanders M, McPartlin D, Moran K, Guo Y, Eeckhout M, O'Kennedy R, et al. . Comparison of enzyme-linked immunosorbent assay, surface plasmon resonance and biolayer interferometry for screening of deoxynivalenol in wheat and wheat dust. Toxins. (2016) 8:103. 10.3390/toxins8040103", "ArticleIdList": ["10.3390/toxins8040103", "PMC4848629", "27077883"]}, {"Citation": "Zhang X, Li G, Wu D, Yu Y, Hu N, Wang H, et al. . Emerging strategies for the activity assay and inhibitor screening of alpha-glucosidase. Food Funct. (2020) 11:66\u201382. 10.1039/C9FO01590F", "ArticleIdList": ["10.1039/C9FO01590F", "31844870"]}, {"Citation": "Chen L, Wang D, Lv D, Wang X, Liu Y, Chen X, et al. . Identification of eupatilin and ginkgolide B as p38 ligands from medicinal herbs by surface plasmon resonance biosensor-based active ingredients recognition system. J Pharm Biomed Anal. (2019) 171:35\u201342. 10.1016/j.jpba.2019.03.029", "ArticleIdList": ["10.1016/j.jpba.2019.03.029", "30965219"]}, {"Citation": "Hu XL, Li YB, Qi S, Zhang Q, Ren TS, Meng WH, et al. . 4-O-galloylalbiflorin discovered from Paeonia lactiflora Pall. is a potential \u03b2-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor. J Funct Foods. (2016) 27:517\u201325. 10.1016/j.jff.2016.10.012", "ArticleIdList": ["10.1016/j.jff.2016.10.012"]}, {"Citation": "Shu X, Duan W, Liu F, Shi X, Geng Y, Wang X, et al. . Preparative separation of polyphenols from the flowers of Paeonia lactiflora Pall. by high-speed counter-current chromatography. J Chromatogr B. (2014) 947-948:62\u20137. 10.1016/j.jchromb.2013.12.004", "ArticleIdList": ["10.1016/j.jchromb.2013.12.004", "24406305"]}, {"Citation": "Qin Y, Tian YP. Protective effects of total glucosides of paeony and the underlying mechanisms in carbon tetrachloride-induced experimental liver injury. Arch Med Sci. (2011) 7:604\u201312. 10.5114/aoms.2011.24129", "ArticleIdList": ["10.5114/aoms.2011.24129", "PMC3258771", "22291795"]}, {"Citation": "Zhang L, Yang B, Yu B. Paeoniflorin protects against nonalcoholic fatty liver disease induced by a high-fat diet in mice. Biol Pharm Bull. (2015) 38:1005\u201311. 10.1248/bpb.b14-00892", "ArticleIdList": ["10.1248/bpb.b14-00892", "25972092"]}, {"Citation": "Ma Z, Chu L, Liu H, Li J, Zhang Y, Liu W, et al. . Paeoniflorin alleviates non-alcoholic steatohepatitis in rats: involvement with the ROCK/NF-\u03baB pathway. Int Immunopharmacol. (2016) 38:377\u201384. 10.1016/j.intimp.2016.06.023", "ArticleIdList": ["10.1016/j.intimp.2016.06.023", "27351828"]}, {"Citation": "Wang H, Wei W, Wang NP, Wu CY, Yan SX, Yue L, et al. . Effects of total glucosides of peony on immunological hepatic fibrosis in rats. World J Gastroenterol. (2005) 11:2124\u20139. 10.3748/wjg.v11.i14.2124", "ArticleIdList": ["10.3748/wjg.v11.i14.2124", "PMC4305781", "15810078"]}, {"Citation": "Zhao Y, Ma X, Wang J, Zhu Y, Li R, Wang J, et al. . Paeoniflorin alleviates liver fibrosis by inhibiting HIF-1\u03b1 through mTOR-dependent pathway. Fitoterapia. (2014) 99:318\u201327. 10.1016/j.fitote.2014.10.009", "ArticleIdList": ["10.1016/j.fitote.2014.10.009", "25454463"]}, {"Citation": "Ma X, Zhao YL, Zhu Y, Chen Z, Wang JB, Li RY, et al. . Paeonia lactiflora Pall. protects against ANIT-induced cholestasis by activating Nrf2 via PI3K/Akt signaling pathway. Drug Des Devel Ther. (2015) 9:5061\u201374. 10.2147/DDDT.S90030", "ArticleIdList": ["10.2147/DDDT.S90030", "PMC4562737", "26366057"]}, {"Citation": "Chen Z, Ma X, Zhu Y, Zhao Y, Wang J, Li R, et al. . Paeoniflorin ameliorates ANIT-induced cholestasis by activating Nrf2 through an PI3K/Akt-dependent pathway in rats. Phytother Res. (2015) 29:1768\u201375. 10.1002/ptr.5431", "ArticleIdList": ["10.1002/ptr.5431", "26269092"]}, {"Citation": "Shen M, Men R, Fan X, Wang T, Huang C, Wang H, et al. . Total glucosides of paeony decreases apoptosis of hepatocytes and inhibits maturation of dendritic cells in autoimmune hepatitis. Biomed Pharmacother. (2020) 124:109911. 10.1016/j.biopha.2020.109911", "ArticleIdList": ["10.1016/j.biopha.2020.109911", "32004939"]}, {"Citation": "Song SS, Yuan PF, Li PP, Wu HX, Ni WJ, Lu JT, et al. . Protective effects of total glucosides of paeony on N-nitrosodiethylamine-induced hepatocellular carcinoma in rats via down-regulation of regulatory B cells. Immunol Invest. (2015) 44:521\u201335. 10.3109/08820139.2015.1043668", "ArticleIdList": ["10.3109/08820139.2015.1043668", "26207789"]}, {"Citation": "Wu JJ, Sun WY, Hu SS, Zhang S, Wei W. A standardized extract from Paeonia lactiflora and Astragalus membranaceus induces apoptosis and inhibits the proliferation, migration and invasion of human hepatoma cell lines. Int J Oncol. (2013) 43:1643\u201351. 10.3892/ijo.2013.2085", "ArticleIdList": ["10.3892/ijo.2013.2085", "24002667"]}, {"Citation": "Li H, Dong L, Liu Y, Wang G, Wang G, Qiao Y. Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats. Int J Pharm. (2014) 466:133\u20138. 10.1016/j.ijpharm.2014.03.014", "ArticleIdList": ["10.1016/j.ijpharm.2014.03.014", "24607203"]}, {"Citation": "Liu B, He H, Luo H, Zhang T, Jiang J. Artificial intelligence and big data facilitated targeted drug discovery. Stroke Vasc Neurol. (2019) 4:206\u201313. 10.1136/svn-2019-000290", "ArticleIdList": ["10.1136/svn-2019-000290", "PMC6979871", "32030204"]}, {"Citation": "Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. (2005) 33:D514\u20137. 10.1093/nar/gki033", "ArticleIdList": ["10.1093/nar/gki033", "PMC539987", "15608251"]}, {"Citation": "Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, et al. . STRING 8\u2013a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. (2009) 37:D412\u20136. 10.1093/nar/gkn760", "ArticleIdList": ["10.1093/nar/gkn760", "PMC2686466", "18940858"]}, {"Citation": "Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. (2003) 13:2498\u2013504. 10.1101/gr.1239303", "ArticleIdList": ["10.1101/gr.1239303", "PMC403769", "14597658"]}, {"Citation": "Cho HJ, Kim JE, Kim DD, Yoon IS. In vitro\u2013in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications. Drug Dev Ind Pharm. (2014) 40:989\u201398. 10.3109/03639045.2013.831439", "ArticleIdList": ["10.3109/03639045.2013.831439", "23981203"]}, {"Citation": "Mudra DR, Borchardt RT. Absorption barriers in the rat intestinal mucosa: 1. application of an in situ perfusion model to simultaneously assess drug permeation and metabolism. J Pharm Sci. (2010) 99:982\u201398. 10.1002/jps.21912", "ArticleIdList": ["10.1002/jps.21912", "19746412"]}, {"Citation": "Yu S, Liu H, Li K, Qin Z, Qin X, Zhu P, et al. . Rapid characterization of the absorbed constituents in rat serum after oral administration and action mechanism of Naozhenning granule using LC\u2013MS and network pharmacology. J Pharm Biomed Anal. (2019) 166:281\u201390. 10.1016/j.jpba.2019.01.020", "ArticleIdList": ["10.1016/j.jpba.2019.01.020", "30682694"]}, {"Citation": "Poynard T, Ratziu V, Charlotte F, Messous D, Munteanu M, Imbert-Bismut F, et al. . Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. (2006) 6:34. 10.1186/1471-230X-6-34", "ArticleIdList": ["10.1186/1471-230X-6-34", "PMC1657015", "17096854"]}, {"Citation": "Delik A, Din\u00e7er S, Akkiz H. The role of genetic and epigenetic factors in non alcoholic fatty liver disease (NAFLD) pathogenesis. Meta Gene. (2020) 24:100647. 10.1016/j.mgene.2020.100647", "ArticleIdList": ["10.1016/j.mgene.2020.100647"]}, {"Citation": "Lee J, Kim Y, Friso S, Choi SW. Epigenetics in non-alcoholic fatty liver disease. Mol Aspects Med. (2017) 54:78\u201388. 10.1016/j.mam.2016.11.008", "ArticleIdList": ["10.1016/j.mam.2016.11.008", "27889327"]}, {"Citation": "Song K, Zhang Y, Ga Q, Bai Z, Ge RL. High-altitude chronic hypoxia ameliorates obesity-induced non-alcoholic fatty liver disease in mice by regulating mitochondrial and AMPK signaling. Life Sci. (2020) 252:117633. 10.1016/j.lfs.2020.117633", "ArticleIdList": ["10.1016/j.lfs.2020.117633", "32289432"]}, {"Citation": "Cordeiro A, Costa R, Andrade N, Silva C, Canabrava N, Pena MJ, et al. . Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity? Clin Res Hepatol Gastroenterol. (2020) 44:394\u2013402. 10.1016/j.clinre.2019.10.001", "ArticleIdList": ["10.1016/j.clinre.2019.10.001", "32044284"]}, {"Citation": "Lago F, G\u00f3mez R, G\u00f3mez-Reino JJ, Dieguez C, Gualillo O. Adipokines as novel modulators of lipid metabolism. Trends Biochem Sci. (2009) 34:500\u201310. 10.1016/j.tibs.2009.06.008", "ArticleIdList": ["10.1016/j.tibs.2009.06.008", "19729309"]}, {"Citation": "Garcia D, Hellberg K, Chaix A, Wallace M, Herzig S, Badur MG, et al. . Genetic liver-specific AMPK activation protects against diet-induced obesity and NAFLD. Cell Rep. (2019) 26:192\u2013208. 10.1016/j.celrep.2018.12.036", "ArticleIdList": ["10.1016/j.celrep.2018.12.036", "PMC6344045", "30605676"]}, {"Citation": "Vazirian M, Nabavi SM, Jafari S, Manayi A. Natural activators of adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) and their pharmacological activities. Food Chem Toxicol. (2018) 122:69\u201379. 10.1016/j.fct.2018.09.079", "ArticleIdList": ["10.1016/j.fct.2018.09.079", "30290216"]}, {"Citation": "Kasangana PB, Eid HM, Nachar A, Stevanovic T, Haddad PS. Further isolation and identification of anti-diabetic principles from root bark of Myrianthus arboreus P. Beauv.: The ethyl acetate fraction contains bioactive phenolic compounds that improve liver cell glucose homeostasis. J Ethnopharmacol. (2019) 245:112167. 10.1016/j.jep.2019.112167", "ArticleIdList": ["10.1016/j.jep.2019.112167", "31422110"]}, {"Citation": "Ziouzenkova O, Plutzky J. Retinoid metabolism and nuclear receptor responses: new insights into coordinated regulation of the PPAR\u2013RXR complex. FEBS Lett. (2008) 582:32\u20138. 10.1016/j.febslet.2007.11.081", "ArticleIdList": ["10.1016/j.febslet.2007.11.081", "18068127"]}, {"Citation": "Bais S, Patel NJ. Role of adiponectin and its target receptors to control deposition of fat in obesity related disorders. Obesity Medicine. (2019) 16:100148. 10.1016/j.obmed.2019.100148", "ArticleIdList": ["10.1016/j.obmed.2019.100148"]}, {"Citation": "Chen Z, Yu R, Xiong Y, Du F, Zhu S. A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease. Lipids Health Dis. (2017) 16:203. 10.1186/s12944-017-0572-9", "ArticleIdList": ["10.1186/s12944-017-0572-9", "PMC5644081", "29037210"]}, {"Citation": "Lee Y, Lee JY. Chapter 8 - protective actions of polyphenols in the development of nonalcoholic fatty liver disease. In: Watson RR, Preedy VR. editors. Dietary Interventions in Liver Disease. London: Academic Press; (2019). p. 91\u20139. 10.1016/B978-0-12-814466-4.00008-2", "ArticleIdList": ["10.1016/B978-0-12-814466-4.00008-2"]}, {"Citation": "Ch\u00e1vez-Tapia NC, Uribe M, Ponciano-Rodr\u00edguez G, Medina-Santill\u00e1n R, M\u00e9ndez-S\u00e1nchez N. New insights into the pathophysiology of nonalcoholic fatty liver disease. Ann Hepatol. (2009) 8:S9\u20137. 10.1016/S1665-2681(19)31821-6", "ArticleIdList": ["10.1016/S1665-2681(19)31821-6", "19381119"]}, {"Citation": "Zhou Z, Liu Y, Miao AD, Wang SQ. Protocatechuic aldehyde suppresses TNF-alpha-induced ICAM-1 and VCAM-1 expression in human umbilical vein endothelial cells. Eur J Pharmacol. (2005) 513:1\u20138. 10.1016/j.ejphar.2005.01.059", "ArticleIdList": ["10.1016/j.ejphar.2005.01.059", "15878704"]}, {"Citation": "Tanaka M, Kishimoto Y, Sasaki M, Sato A, Kamiya T, Kondo K, et al. . Terminalia bellirica (Gaertn.) Roxb. extract and gallic acid attenuate LPS-induced inflammation and oxidative stress via MAPK/NF-\u03baB and Akt/AMPK/Nrf2 pathways. Oxid Med Cell Longev. (2018) 2018:9364364. 10.1155/2018/9364364", "ArticleIdList": ["10.1155/2018/9364364", "PMC6250009", "30533177"]}, {"Citation": "Grattagliano I, de Bari O, Bernardo TC, Oliveira PJ, Wang DQH, Portincasa P. Role of mitochondria in nonalcoholic fatty liver disease-from origin to propagation. Clin Biochem. (2012) 45:610\u20138. 10.1016/j.clinbiochem.2012.03.024", "ArticleIdList": ["10.1016/j.clinbiochem.2012.03.024", "22484459"]}, {"Citation": "Stanley WC, Sabbah HN. Metabolic therapy for ischemic heart disease: the rationale for inhibition of fatty acid oxidation. Heart Fail Rev. (2005) 10:275\u20139. 10.1007/s10741-005-7542-4", "ArticleIdList": ["10.1007/s10741-005-7542-4", "16583175"]}, {"Citation": "Gu F, Chauhan V, Kaur K, Brown WT, LaFauci G, Wegiel J, et al. . Alterations in mitochondrial DNA copy number and the activities of electron transport chain complexes and pyruvate dehydrogenase in the frontal cortex from subjects with autism. Transl Psychiatry. (2013) 3:e299. 10.1038/tp.2013.68", "ArticleIdList": ["10.1038/tp.2013.68", "PMC3784762", "24002085"]}, {"Citation": "Marquez J, Flores J, Kim AH, Nyamaa B, Nguyen ATT, Park N, et al. . Rescue of TCA cycle dysfunction for cancer therapy. J Clin Med. (2019) 8:2161. 10.3390/jcm8122161", "ArticleIdList": ["10.3390/jcm8122161", "PMC6947145", "31817761"]}, {"Citation": "Stevanovi\u0107 J, Beleza J, Coxito P, Ascens\u00e3o A, Magalh\u00e3es J. Physical exercise and liver \u201cfitness\u201d: role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease. Mol Metab. (2020) 32:1\u201314. 10.1016/j.molmet.2019.11.015", "ArticleIdList": ["10.1016/j.molmet.2019.11.015", "PMC6931125", "32029220"]}, {"Citation": "Song S, Xiao X, Guo D, Mo L, Bu C, Ye W, et al. . Protective effects of Paeoniflorin against AOPP-induced oxidative injury in HUVECs by blocking the ROS-HIF-1\u03b1/VEGF pathway. Phytomedicine. (2017) 34:115\u201326. 10.1016/j.phymed.2017.08.010", "ArticleIdList": ["10.1016/j.phymed.2017.08.010", "28899493"]}, {"Citation": "Xu YJ, Mei Y, Shi XQ, Zhang YF, Wang XY, Guan L, et al. . Albiflorin ameliorates memory deficits in APP/PS1 transgenic mice via ameliorating mitochondrial dysfunction. Brain Res. (2019) 1719:113\u201323. 10.1016/j.brainres.2019.05.037", "ArticleIdList": ["10.1016/j.brainres.2019.05.037", "31150651"]}, {"Citation": "Ren L, Zhou X, Huang X, Wang C, Li Y. The IRS/PI3K/Akt signaling pathway mediates olanzapine-induced hepatic insulin resistance in male rats. Life Sci. (2019) 217:229\u201336. 10.1016/j.lfs.2018.12.015", "ArticleIdList": ["10.1016/j.lfs.2018.12.015", "30550886"]}, {"Citation": "Dai B, Wu Q, Zeng C, Zhang J, Cao L, Xiao Z, et al. . The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance. J Ethnopharmacol. (2016) 192:382\u20139. 10.1016/j.jep.2016.07.024", "ArticleIdList": ["10.1016/j.jep.2016.07.024", "27401286"]}, {"Citation": "Fan Y, He Z, Wang W, Li J, Hu A, Li L, et al. . Tangganjian decoction ameliorates type 2 diabetes mellitus and nonalcoholic fatty liver disease in rats by activating the IRS/PI3K/AKT signaling pathway. Biomed. Pharmacother. (2018) 106:733\u20137. 10.1016/j.biopha.2018.06.089", "ArticleIdList": ["10.1016/j.biopha.2018.06.089", "29990865"]}, {"Citation": "Jeong MY, Park J, Youn DH, Jung Y, Kang J, Lim S, et al. . Albiflorin ameliorates obesity by inducing thermogenic genes via AMPK and PI3K/AKT in vivo and in vitro. Metabolism. (2017) 73:85\u201399. 10.1016/j.metabol.2017.05.009", "ArticleIdList": ["10.1016/j.metabol.2017.05.009", "28732574"]}, {"Citation": "Ma Z, Chu L, Liu H, Wang W, Li J, Yao W, et al. . Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats. Sci Rep. (2017) 7:44819. 10.1038/srep44819", "ArticleIdList": ["10.1038/srep44819", "PMC5353673", "28300221"]}, {"Citation": "Wang G, Ji Y, Li X, Wang Q, Gong H, Wang B, et al. . Utilizing the combination of binding kinetics and micro-pharmacokinetics link in vitro \u03b1-Glucosidase inhibition to in vivo target occupancy. Biomolecules. (2019) 9:493. 10.3390/biom9090493", "ArticleIdList": ["10.3390/biom9090493", "PMC6770063", "31527517"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "3", "Day": "8"}, {"Year": "2021", "Month": "8", "Day": "23"}, {"Year": "2021", "Month": "10", "Day": "4", "Hour": "6", "Minute": "8"}, {"Year": "2021", "Month": "10", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "5", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["34604271", "PMC8481579", "10.3389/fnut.2021.677659"]}}], "PubmedBookArticle": []}